New Insight on How to Build a Better Flu Vaccine – For Long-Lasting Immunity Against New Influenza Strains
Flu season comes around like clockwork every year, and sooner or later everyone gets infected. The annual flu shot is a key part of public…
Flu season comes around like clockwork every year, and sooner or later everyone gets infected. The annual flu shot is a key part of public…
UNC-Chapel Hill study raises concern that COVID-19 vaccine will be less effective for those with obesity. A review of COVID-19 studies reveals a troubling connection…
Nasal delivery produces more widespread immune response than intramuscular injection. Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that…
As scientists around the world rush to learn more about COVID-19, several labs at the University of Chicago’s Pritzker School of Molecular Engineering are taking…
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing. The investigational vaccine known as mRNA-1273 protected mice from…
Vaccine prevents pneumonia, elicits high levels of protective antibodies in mice. An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19…
BCG vaccine is safe and does not lead to an increased risk of COVID-19 symptoms. More studies need to confirm whether this generic vaccine could…
New research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself, could offer effective treatment for a range of…
Researchers caution: It is too soon to say whether pre-existing immune cell memory affects COVID-19 clinical outcomes. Your immune system’s “memory” T cells keep track…
Study shows that peptide nanofibers induce immune response in lungs and lymph nodes without requiring adjuvants for efficacy, indicating promise for new vaccine development. The…
The virus causing the COVID-19 pandemic, SARS-CoV-2, presents at least six strains. Despite its mutations, the virus shows little variability, and this is good news…
Study of low- and middle-income country programs highlights the huge costs of preventable diseases compared to the costs of immunizing against them. Immunization programs offered…
Responding to a need to quickly develop billions of doses of lifesaving COVID-19 vaccines, a scientific team at The University of Texas at Austin has…
Findings lay groundwork for clinical development program. The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A…
Scientists at the Milner Centre for Evolution looked at the evolution of the virus that causes Covid19; their findings could help the design of a…
Findings confirm the robustness of the vaccine approval system and postmarketing surveillance. A comprehensive review of vaccine data over a 20-year period finds that vaccines…
A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine,…
The rate of seasonal flu vaccinations among people over age 50 and nursing home residents is extremely low, and those who do get the flu…